SPDR S&P Biotech ETF
349 hedge funds and large institutions have $3.77B invested in SPDR S&P Biotech ETF in 2017 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 130 increasing their positions, 86 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
349
Holders Change
+35
Holders Change %
+11.15%
% of All Funds
8.71%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.45%
New
70
Increased
130
Reduced
86
Closed
34
Calls
$776M
Puts
$1.51B
Net Calls
-$735M
Net Calls Change
-$133M
Top Buyers
Top Sellers
1 |
Citigroup
New York
|
$425M |
2 |
BNP Paribas Financial Markets
Paris,
France
|
$347M |
3 |
![]()
JPMorgan Chase & Co
New York
|
$174M |
4 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
$59.3M |
5 |
Goldman Sachs
New York
|
$480M |